Home > NRC Library > ADAMS Public Documents

655859 Amendment No. 11 for POINT Biopharma USA Inc. to License No. 13-35593-01

Accession Number: ML26138A009

Date Released: Friday, May 22, 2026

Package Contents

The following links on this page are to Adobe Portable Document Format (PDF) files. To obtain a free viewer for displaying this format, see our Plugins, Viewers, and Other Tools.

• ML26138A006 - 655859 Cover Letter for POINT Biopharma USA Inc. to License No. 13-35593-01 (5/15/2026)
• ML26056A188 - 655859 Request for Amendment to POINT Biopharma USA Inc., License No. 13-35593-01 (12/1/2025)